Efficacy of omalizumab treatment in a man with occupational asthma and eosinophilic granulomatosis with polyangioitis

Ann Allergy Asthma Immunol. 2018 Feb;120(2):209-211. doi: 10.1016/j.anai.2017.10.034. Epub 2017 Dec 28.

Authors

Cristiano Caruso¹, Giorgia Gencarelli², Francesco Gaeta³, Rocco Luigi Valluzzi³, Gabriele Rumi³, Antonino Romano⁴

Affiliations

¹ Allergy Unit, Policlinico Agostino Gemelli Hospital, Rome, Italy. Electronic address: [email protected].
² Sant'Andrea Hospital, Massa Marittima, Italy.
³ Allergy Unit, Policlinico Agostino Gemelli Hospital, Rome, Italy.
⁴ Allergy Unit, Policlinico Agostino Gemelli Hospital, Rome, Italy; IRCCS Oasi Maria SS, Troina, Italy.

PMID: 29290513
DOI: 10.1016/j.anai.2017.10.034

No abstract available

Publication types

Case Reports

MeSH terms

Allergens / immunology
Anti-Asthmatic Agents / therapeutic use*
Asthma, Occupational / diagnosis
Asthma, Occupational / drug therapy*
Churg-Strauss Syndrome / diagnosis
Churg-Strauss Syndrome / drug therapy*
Disease Progression
Emergency Medical Services
Eosinophils / immunology*
Fish Products
Fish Proteins / immunology
Food Hypersensitivity / diagnosis
Food Hypersensitivity / drug therapy*
Humans
Immunoglobulin E / immunology
Immunoglobulin E / metabolism
Male
Middle Aged
Omalizumab / therapeutic use*
Paranasal Sinuses / diagnostic imaging
Paranasal Sinuses / pathology*
Restaurants
Tomography, X-Ray Computed

Substances

Allergens
Anti-Asthmatic Agents
Fish Proteins
Omalizumab
Immunoglobulin E